IO Biotech, Inc. - Common Stock (IOBT)

Which stocks have an unusual volume on Monday?

Curious about what's happening in today's session? Check out the latest stock movements and price changes.

Unusual volume stocks are being observed in Friday's session.

Unusual volume stocks are being observed in Tuesday's session.

Intrigued by the market activity in the middle of the day on Tuesday? Uncover the key winners and losers of today's session in our insightful analysis.

As the regular session of the US market on Monday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.

Wondering how the US markets performed one hour before the close of the markets on Monday? Discover the movers and shakers of today's session in our comprehensive analysis.

Here are the top movers in Monday's session, showcasing the stocks with significant price changes.

The company said Cylembio plus Keytruda demonstrated clinical improvement in progression-free survival compared to Keytruda alone, but statistical significance was “narrowly” missed.

IO Biotech's Phase 3 trial showed Cylembio plus Keytruda improved progression-free survival in advanced melanoma across most subgroups.

Before the opening bell on Monday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.

Discover the top movers in Friday's after-hours session and stay informed about the post-market dynamics.

Keep an eye on the top gainers and losers in Tuesday's session, as they reflect the most notable price movements.